Important Safety Information

Important Safety Information

QVAR® is not a bronchodilator and is not indicated for relief of acute bronchospasm. Common side effects associated with the use of QVAR® and placebo in clinical trials include, but are not limited to, headache (12% and 9%, respectively) and pharyngitis (8% and 4%, respectively). Caution: Adrenal insufficiency may occur when transferring patients from systemic steroids (see WARNINGS, Prescribing Information). A reduction in growth velocity in growing children and teenagers may occur as a result of inadequate control of chronic diseases such as asthma or from use of corticosteroids for treatment.

Teva's Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on management's current beliefs and expectations and involve a number of known and unknown risks and uncertainties that could cause our future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully develop and commercialize additional pharmaceutical products, the introduction of competing generic equivalents, the extent to which we may obtain U.S. market exclusivity for certain of our new generic products and regulatory changes that may prevent us from utilizing exclusivity periods, potential liability for sales of generic products prior to a final resolution of outstanding patent litigation, including that relating to the generic versions of Neurontin®, Lotrel® and Protonix®, the extent to which any manufacturing or quality control problems damage our reputation for high quality production, the effects of competition on sales of our innovative products, especially Copaxone® (including potential generic and oral competition for Copaxone®), the impact of continuing consolidation of our distributors and customers, our ability to identify, consummate and successfully integrate acquisitions, interruptions in our supply chain or problems with our information technology systems that adversely affect our complex manufacturing processes, intense competition in our specialty pharmaceutical businesses, any failures to comply with the complex Medicare and Medicaid reporting and payment obligations, our exposure to currency fluctuations and restrictions as well as credit risks, the effects of reforms in healthcare regulation, adverse effects of political or economical instability, major hostilities or acts of terrorism on our significant worldwide operations, increased government scrutiny in both the U.S. and Europe of our agreements with brand companies, dependence on the effectiveness of our patents and other protections for innovative products, our ability to achieve expected results through our innovative R&D efforts, the difficulty of predicting U.S. Food and Drug Administration, European Medicines Agency and other regulatory authority approvals, uncertainties surrounding the legislative and regulatory pathway for the registration and approval of biotechnology-based products, potentially significant impairments of intangible assets and goodwill, potential increases in tax liabilities resulting from challenges to our intercompany arrangements, our potential exposure to product liability claims to the extent not covered by insurance, the termination or expiration of governmental programs or tax benefits, current economic conditions, any failure to retain key personnel or to attract additional executive and managerial talent, environmental risks and other factors that are discussed in this report and in our other filings with the U.S. Securities and Exchange Commission ("SEC").

Our Body Work as a Team?

What Does "Tissue" Mean, and Do the Tissues Throughout Our
Body Work as a Team?
Humans are truly a complex array of organs and other tissues designed
to support the basic functions and vitality of our body. We are able to
process inhaled air and ingested food and regulate body content. We
selectively take what we need from the external environment and elimin-
ate what we do not need. We think, move about, and reproduce. Many of
these operations occur without us even being aware of them.
 One other term we should be familiar with is tissue. Quite
simply, tissue is composed of similar or cooperating cells performing
similar or cooperative tasks. These cells may be grouped together to form
fascinating tissues such as bone, skin, muscle, nerves, and blood.

Extracellular Fluids?

What Types of Substances Are Found in the Intracellular and
Extracellular Fluids?
In our body fluids we would find small dissolved substances such as ions,
amino acids, and the carbohydrate glucose, as well as larger proteins. The
major ions (or electrolytes) would include potassium (K+), sodium
(Na+), chloride (Cl−), calcium (Ca2+), magnesium (Mg2+), phosphate
(PO43−), and bicarbonate (HCO3−). As demonstrated in Figure 2.2, all of
these and other substances will be found in both the intracellular and
extracellular fluids. However, the concentration of substances dissolved
in either fluid varies and the plasma membrane is bestowed with the
awesome responsibility of functioning as a barrier between the two
mediums.